Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 2
Submit an article Journal homepage
907
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Expression and significance of mammalian target of rapamycin in cutaneous squamous cell carcinoma and precancerous lesions

Gongjun XuDepartment of Dermatology,Jinhua Fifth Hospital, JinHua, ZheJiang,ChinaCorrespondence[email protected]
View further author information
,
Jinxian FangDepartment of Dermatology,Jinhua Fifth Hospital, JinHua, ZheJiang,ChinaView further author information
,
Jinlun XuDepartment of Dermatology,Jinhua Fifth Hospital, JinHua, ZheJiang,ChinaView further author information
,
Zhen ShenDepartment of Dermatology,Jinhua Fifth Hospital, JinHua, ZheJiang,ChinaView further author information
,
Chiqing HuangDepartment of Dermatology,Jinhua Fifth Hospital, JinHua, ZheJiang,ChinaView further author information
&
Yixiu JiangDepartment of Dermatology,Jinhua Fifth Hospital, JinHua, ZheJiang,ChinaView further author information
Pages 9930-9938 | Received 13 Aug 2021, Accepted 20 Sep 2021, Published online: 07 Dec 2021

References

  • Werner RN, Sammain A, Erdmann R, et al. The natural history of actinic keratosis: asystematic review. Br J Dermatol. 2013;169(3):502–518.
  • Jr PJ, Janku F. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol Ther. 2014;142(2):164–175.
  • Shin E, Choi CM, Kim HR, et al. Immunohistochemical characterization of the mTOR pathway in stage-I non-small-cell lung carcinoma. Lung Cancer. 2015;89(1):13–18.
  • Ressel BS, Massone AR, Barbeito CG. Immunohistochemical expression of selected phosphoproteins of the mTOR signalling pathway in canine cutaneous squamous cell carcinoma. Vet J. 2019;245:41–48.
  • Kang J, Suh EE. Development and Evaluation of “Chronic Illness Care Smartphone Apps” on Nursing Students’ Knowledge, Self-efficacy, and Learning Experience. Comput Inform Nurs. 2018;36(11):550–559.
  • Liu Y, Chen W. A SAS macro for testing differences among three or more independent groups using Kruskal-Wallis and Nemenyi tests. J Huazhong Univ Sci Technolog Med Sci. 2012;32(1):130–134.
  • West NG, Ilief-Ala MA, Douglass JM, et al. Factors associated with sealant outcome in 2 pediatric dental clinics: a multivariate hierarchical analysis. Pediatr Dent. 2011;33(4):333–337.
  • De Winter JC, Gosling SD, Potter J. Comparing the Pearson and Spearman correlation coefficients across distributions and sample sizes: a tutorial using simulations and empirical data. Psychol Methods. 2016;21(3):273–290.
  • Chamcheu JC, Roy T, Uddin MB, et al. Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: a Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy. Cells. 2019;8(8):803.
  • Schaper-Gerhardt K, Walter A, Schmitz-Rode C, et al. The mTOR-inhibitor Sirolimus decreases the cyclosporine-induced expression of the oncogene ATF3 in human keratinocytes. J Dermatol Sci. 2018;92(2):172–180.
  • Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166(5):1069–1080.
  • Stasko T, Brown MD, Carucci JA, et al. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg. 2004;30(4 Pt 2):642–650.
  • Leo MS, Sivamani RK. Phytochemical modulation of the Akt/mTOR pathway and its potential use in cutaneous disease. Arch Dermatol Res. 2014;306(10):861–871.
  • Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149(2):274–293.
  • Vahidnezhad H, Youssefian L, Uitto J. Molecular Genetics of the PI3K-AKT-mTOR Pathway in Genodermatoses: diagnostic Implications and Treatment Opportunities. J Invest Dermatol. 2016;136(1):15–23.
  • Kezic A, Popovic L, Lalic K. mTOR Inhibitor Therapy and Metabolic Consequences: where Do We Stand? Oxid Med Cell Longev. 2018;2018:2640342.
  • Gargalionis AN, Malakou LS, Adamopoulos C, et al. Polycystin-1 downregulation induces ERK-dependent mTOR pathway activation in a cellular model of psoriasis. Biochim Biophys Acta Mol Basis Dis. 2018;1864(10):3468–3476.
  • Monfrecola G, Lembo S, Caiazzo G, et al. Mechanistic target of rapamycin (mTOR) expression is increased in acne patients’ skin. Exp Dermatol. 2016;25(2):153–155.
  • Keysar SB, Le PN, Miller B, et al. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2. J Natl Cancer Inst. 2016;109(1):djw189.
  • Li Z, Yang Z, Passaniti A, et al. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation. Oncotarget. 2016;7(22):31892–31906.
  • Simpson DR, Mell LK, Cohen EE. Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck. Oral Oncol. 2015;51(4):291–298.
  • García-Carracedo D, MÁ V, Álvarez-Teijeiro S, et al. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas. Oncotarget. 2016;7(20):29780–29793.
  • Komiya T, Memmott RM, Blumenthal GM, et al. A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancer. Transl Lung Cancer Res. 2019;8(3):247–257.
  • Karavasilis V, Samantas E, Koliou GA, et al. Gemcitabine Combined with the mTOR Inhibitor Temsirolimus in Patients with Locally Advanced or Metastatic Pancreatic Cancer. A Hellenic Cooperative Oncology Group Phase I/II Study. Target Oncol. 2018;13(6):715–724.
  • Zou Y, Ge M, Targeting WX. PI3K-AKT-mTOR by LY3023414 inhibits human skin squamous cell carcinoma cell growth in vitro and in vivo. Biochem Biophys Res Commun. 2017;490(2):385–392.
  • Monaco AP. The role of mTOR inhibitors in the management of posttransplant malignancy. Transplantation. 2009;87(2):157–163.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.